###begin article-title 0
Myeloid heme oxygenase-1 regulates innate immunity and autoimmunity by modulating IFN-beta production
###end article-title 0
###begin p 1
###xml 301 305 301 305 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">M-KO</sup>
###xml 687 709 684 706 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Listeria monocytogenes</italic>
###xml 306 310 <span type="species:ncbi:10090">mice</span>
###xml 668 672 <span type="species:ncbi:10090">mice</span>
###xml 687 709 <span type="species:ncbi:1639">Listeria monocytogenes</span>
###xml 819 823 <span type="species:ncbi:10090">mice</span>
###xml 920 924 <span type="species:ncbi:10090">mice</span>
Heme oxygenase-1 (HO-1) is a key cytoprotective, antioxidant, and antiinflammatory molecule. The pathophysiological functions of HO-1 have been associated with its enzymatic activities in heme catabolism. We have examined the immune functions of HO-1 by its conditional ablation in myeloid cells (HO-1M-KO mice). We demonstrate that myeloid HO-1 is required for the activation of interferon (IFN) regulatory factor (IRF) 3 after Toll-like receptor 3 or 4 stimulation, or viral infection. HO-1-deficient macrophages show reduced expression of IFN-beta and of primary IRF3 target genes encoding RANTES, IP-10 and MCP-1. In the presence of polyI:C, myeloid HO-1 knockout mice infected with Listeria monocytogenes, a model dependent on IFN-beta production, showed enhanced bacterial clearance and survival, whereas control mice succumbed to infection. Moreover, after induction of experimental autoimmune encephalomyelitis, mice with myeloid-specific HO-1 deficiency developed a higher incidence and an exacerbated, nonremitting clinical disease correlating with persistent activation of antigen-presenting cells, enhanced infiltration of Th17 cells, and a nonregressing myelin-specific T cell reactivity. Notably, these defects were rectified by exogenous administration of IFN-beta, confirming that HO-1 functions directly upstream of this critical immune pathway. These results uncover a novel direct function for myeloid HO-1 in the regulation of IFN-beta production, establishing HO-1 as a critical early mediator of the innate immune response.
###end p 1
###begin p 2
###xml 407 408 400 401 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib1">1</xref>
###xml 425 426 418 419 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib2">2</xref>
###xml 451 452 444 445 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib3">3</xref>
###xml 454 455 447 448 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib4">4</xref>
###xml 493 494 486 487 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib5">5</xref>
###xml 870 871 860 861 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib6">6</xref>
###xml 873 874 863 864 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib7">7</xref>
###xml 1406 1407 1378 1379 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib8">8</xref>
###xml 1515 1516 1484 1485 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib9">9</xref>
Recent advances have provided a clearer picture of the pathways by which the innate immune system senses bacterial and viral pathogens, and how this leads to the production of type I IFNs. This process is primarily mediated by the engagement of specific Toll-like receptors (TLRs) but also by TLR-independent pathways. The specific ligands recognized by IFN-alpha/beta-inducing TLRs include dsRNA for TLR3 (1), LPS for TLR4 (2), ssRNA for TLR7 and 8 (3, 4), and unmethylated CpG-DNA for TLR9 (5). Ligand binding leads to TLR dimerization and conformational changes in both the receptor ectodomains and the cytoplasmic TLR-IL-1R (TIR) domains. TIR domains bind specific adaptors: TIR domain-containing adaptor inducing IFN-beta (TRIF) for TLR3; TRIF-related adaptor molecule, TRIF, TIR domain-containing adaptor protein, and MyD88 for TLR4; and MyD88 for TLR7, 8, and 9 (6, 7). These adaptors propagate signaling by recruiting kinases that mediate activation of the transcription factors adaptor protein 1 (AP-1; heterodimer of activating transcription factor 2 and c-Jun), NF-kappaB, IFN regulatory factor (IRF) 3, and IRF7, which are all required for IFN-alpha/beta production. Two cytosolic RNA helicases, retinoic acid-inducible gene I (RIG-I) and melanoma differentiation-associated gene 5 (MDA5), mediate TLR-independent IFN-alpha/beta induction by actively replicating RNA viruses and synthetic RNA (8). RIG-I and MDA5 bind through caspase recruitment domains to mitochondrial IFN-beta promoter stimulator 1 (9), initiating signaling cascades that lead to IRF3, IRF7, NF-kB, and AP-1 activation, and IFN-alpha/beta expression. In addition to viral cytosolic RNA, bacterial cytosolic DNA also triggers TLR-independent type I IFN production through an as yet not fully defined pathway that requires IRF3, but not activation of NF-kappaB and mitogen-activated protein kinases (MAPKs).
###end p 2
###begin p 3
###xml 206 208 206 208 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib10">10</xref>
###xml 210 212 210 212 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib11">11</xref>
###xml 367 369 367 369 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib12">12</xref>
###xml 432 434 432 434 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib13">13</xref>
###xml 490 492 490 492 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib14">14</xref>
###xml 584 586 584 586 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib15">15</xref>
###xml 587 589 587 589 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib20">20</xref>
###xml 218 224 <span type="species:ncbi:9606">humans</span>
###xml 372 376 <span type="species:ncbi:10090">Mice</span>
Heme oxygenase-1 (HO-1) is a key cytoprotective, antioxidant, and antiinflammatory molecule. Most of the physiological functions of HO-1 have been associated with its enzymatic activity in heme catabolism (10, 11). In humans, HO-1 deficiency is associated with susceptibility to oxidative stress and an increased proinflammatory state with severe endothelial damage (12). Mice lacking HO-1 develop progressive inflammatory disease (13) and show enhanced sensitivity to LPS-induced toxemia (14). The protective properties of HO-1 have been studied in a variety of inflammatory models (15-20); however, the molecular mechanisms, timing, and mode of HO-1 function in disease remain largely unknown.
###end p 3
###begin p 4
###xml 142 144 142 144 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib16">16</xref>
###xml 146 148 146 148 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib17">17</xref>
###xml 1089 1111 1079 1101 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Listeria monocytogenes</italic>
###xml 1000 1012 <span type="species:ncbi:11191">Sendai virus</span>
###xml 1014 1017 <span type="species:ncbi:11191">SeV</span>
###xml 1070 1074 <span type="species:ncbi:10090">mice</span>
###xml 1089 1111 <span type="species:ncbi:1639">Listeria monocytogenes</span>
###xml 1251 1255 <span type="species:ncbi:10090">mice</span>
###xml 1380 1384 <span type="species:ncbi:10090">mice</span>
Earlier studies have shown that HO-1 expression or CO administration mediate potent antiinflammatory effects in monocytes and/or macrophages (16, 17), probably restraining these cells from inducing tissue injury and possibly modulating their role in the initiation of immune responses. However, little is known about the signaling pathways that are regulated by HO-1 in macrophages, a cell type central to the initiation of immune and autoimmune responses. In this study, we sought to examine the function of HO-1 in immune responses by conditional ablation of HO-1 gene expression, specifically in macrophages. We demonstrate that HO-1 is not essential for TLR4/MyD88-induced NF-kappaB and MAPK activation and subsequent proinflammatory cytokine production, but is required for TLR4/TLR3/IRF3-induced production of IFN-beta and primary IRF3 target genes in macrophages. In addition, IRF3 activation and subsequent IFN-beta production was severely impaired in HO-1 knockout macrophages infected with Sendai virus (SeV). In the presence of polyI:C, myeloid HO-1 knockout mice infected with Listeria monocytogenes, an infectious model with enhanced severity that is dependent on IFN-beta production, showed enhanced bacterial clearance, whereas control mice succumbed to infection. Furthermore, myeloid HO-1 deficiency exacerbated experimental autoimmune encephalomyelitis (EAE) in mice that was associated with defective IFN-beta production and enhanced infiltration of activated macrophages and Th17 cells in the central nervous system (CNS).
###end p 4
###begin title 5
RESULTS
###end title 5
###begin title 6
###xml 56 60 <span type="species:ncbi:10090">mice</span>
Ubiquitous and myeloid-specific inactivation of HO-1 in mice
###end title 6
###begin p 7
###xml 108 113 108 113 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Hmox1</italic>
###xml 122 130 122 130 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig1">Fig. 1 A</xref>
###xml 182 187 182 187 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Hmox1</italic>
###xml 199 202 199 202 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">D/D</sup>
###xml 194 202 194 202 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Hmox1<sup>D/D</sup></italic>
###xml 210 212 210 212 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">KO</sup>
###xml 236 241 236 241 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FL/FL</sup>
###xml 231 241 231 241 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Hmox1<sup>FL/FL</sup></italic>
###xml 298 300 298 300 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib21">21</xref>
###xml 328 333 328 333 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Hmox1</italic>
###xml 377 385 377 385 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig1">Fig. 1 B</xref>
###xml 447 452 435 440 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Hmox1</italic>
###xml 454 455 442 443 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">D</italic>
###xml 452 455 440 443 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/<italic>D</italic></sup>
###xml 481 484 469 472 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">D/D</sup>
###xml 477 484 465 472 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Hmox<sup>D/D</sup></italic>
###xml 528 530 516 518 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib13">13</xref>
###xml 593 595 581 583 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">KO</sup>
###xml 719 727 707 715 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig1">Fig. 1 C</xref>
###xml 885 887 873 875 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">KO</sup>
###xml 948 956 936 944 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig1">Fig. 1 D</xref>
###xml 70 74 <span type="species:ncbi:10090">mice</span>
###xml 145 149 <span type="species:ncbi:10090">mice</span>
###xml 213 217 <span type="species:ncbi:10090">mice</span>
###xml 242 246 <span type="species:ncbi:10090">mice</span>
###xml 252 267 <span type="species:ncbi:10090">transgenic mice</span>
###xml 456 460 <span type="species:ncbi:10090">mice</span>
###xml 485 489 <span type="species:ncbi:10090">mice</span>
###xml 596 600 <span type="species:ncbi:10090">mice</span>
###xml 888 892 <span type="species:ncbi:10090">mice</span>
To investigate the function of HO-1 in immune responses, we generated mice with conditional deletion of the Hmox1 allele (Fig. 1 A). To generate mice with ubiquitous deletion of the Hmox1 gene (Hmox1D/D or HO-1KO mice), we crossed Hmox1FL/FL mice with transgenic mice expressing Cre in germ cells (21). We confirmed deletion of Hmox1 in the germline by Southern blot analysis (Fig. 1 B). Of approximately622 newborn pups obtained by intercrossing Hmox1+/D mice, we obtained 25 HmoxD/D mice, indicating, as previously described (13), that the HO-1 deficiency is partially embryonic lethal. HO-1KO mice showed a progressive chronic inflammatory disease characterized by enlarged spleens and hepatic inflammatory lesions (Fig. 1 C), and died within 6 mo because of presumed multiorgan failure. Immunoblot analysis of thioglycollate-elicited peritoneal macrophage (TEPM) extracts from HO-1KO mice showed complete ablation of HO-1 at the protein level (Fig. 1 D).
###end p 7
###begin p 8
###xml 35 40 35 40 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Hmox1</italic>
###xml 0 67 0 67 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Generation and characterization of <italic>Hmox1</italic> conditional knockout mice.</bold>
###xml 108 113 108 113 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Hmox1</italic>
###xml 240 245 240 245 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FL/FL</sup>
###xml 235 245 235 245 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Hmox1<sup>FL/FL</sup></italic>
###xml 285 288 285 288 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Cre</italic>
###xml 358 363 358 363 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Hmox1</italic>
###xml 460 463 460 463 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Nhe</italic>
###xml 766 769 766 769 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/+</sup>
###xml 762 769 762 769 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Hmox<sup>+/+</sup></italic>
###xml 778 781 778 781 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">D/D</sup>
###xml 774 781 774 781 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Hmox<sup>D/D</sup></italic>
###xml 898 901 894 897 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/+</sup>
###xml 894 901 890 897 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Hmox<sup>+/+</sup></italic>
###xml 903 904 899 900 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib1">1</xref>
###xml 912 917 908 913 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FL/FL</sup>
###xml 907 917 903 913 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Hmox1<sup>FL/FL</sup></italic>
###xml 919 920 915 916 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib2">2</xref>
###xml 927 932 923 928 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Cre/+</sup>
###xml 937 942 933 938 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FL/FL</sup>
###xml 923 942 919 938 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LysM<sup>Cre/+</sup>Hmox1<sup>FL/FL</sup></italic>
###xml 944 945 940 941 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib3">3</xref>
###xml 952 957 948 953 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Cre/+</sup>
###xml 962 966 958 962 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">D/FL</sup>
###xml 948 966 944 962 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LysM<sup>Cre/+</sup>Hmox1<sup>D/FL</sup></italic>
###xml 968 969 964 965 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib4">4</xref>
###xml 980 983 976 979 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">D/D</sup>
###xml 976 983 972 979 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Hmox<sup>D/D</sup></italic>
###xml 985 986 981 982 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib5">5</xref>
###xml 62 66 <span type="species:ncbi:10090">mice</span>
###xml 102 107 <span type="species:ncbi:10090">mouse</span>
###xml 246 250 <span type="species:ncbi:10090">mice</span>
###xml 315 319 <span type="species:ncbi:10090">mice</span>
###xml 782 786 <span type="species:ncbi:10090">mice</span>
###xml 988 992 <span type="species:ncbi:10090">mice</span>
Generation and characterization of Hmox1 conditional knockout mice. (A) The genomic structures of the mouse Hmox1 gene, the targeting vector, and the floxed (FL) and defloxed (D) alleles are shown. Black boxes denote coding sequences. Hmox1FL/FL mice were crossed with the appropriate Cre-bearing deleter to obtain mice with ubiquitous or cell-type specific Hmox1 deficiencies. (B) Southern blot analysis of offsprings. Genomic DNA was extracted digested with NheI (Nh), electrophoresed, and hybridized with the probe indicated in A. The blotting gave a single 8.8-kb band for the wild-type allele, a single 11-kb band for the floxed allele, and a single 12-kb band for the defloxed (D) allele. (C) Spleen (a and b) and hepatic (c and d) sections from 16-wk-old Hmox+/+ and HmoxD/D mice stained with H&E. Bars, 100 microM. (D) Immunoblot analysis for the expression of HO-1 protein. TEPMs from Hmox+/+ (1), Hmox1FL/FL (2), LysMCre/+Hmox1FL/FL (3), LysMCre/+Hmox1D/FL (4), and HmoxD/D (5) mice were stimulated with 50 microM hemin for 24 h, lysed, and blotted with anti-HO-1 antibody. The WCEs were simultaneously blotted with anti-beta-actin antibody. Black lines indicate that intervening lanes have been spliced out.
###end p 8
###begin p 9
###xml 57 62 57 62 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FL/FL</sup>
###xml 52 62 52 62 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Hmox1<sup>FL/FL</sup></italic>
###xml 73 77 73 77 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LysM</italic>
###xml 100 104 100 104 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LysM</italic>
###xml 140 143 140 143 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">lox</italic>
###xml 196 198 196 198 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib22">22</xref>
###xml 243 247 243 247 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LysM</italic>
###xml 247 250 247 250 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Cre</italic>
###xml 247 252 247 252 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><italic>Cre</italic>/+</sup>
###xml 252 257 252 257 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Hmox1</italic>
###xml 257 262 257 262 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FL/FL</italic>
###xml 257 262 257 262 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><italic>FL/FL</italic></sup>
###xml 267 271 267 271 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LysM</italic>
###xml 271 274 271 274 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Cre</italic>
###xml 271 276 271 276 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><italic>Cre</italic>/+</sup>
###xml 276 281 276 281 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Hmox1</italic>
###xml 281 285 281 285 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">D/FL</italic>
###xml 281 285 281 285 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><italic>D/FL</italic></sup>
###xml 393 398 393 398 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FL/FL</sup>
###xml 388 398 388 398 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Hmox1<sup>FL/FL</sup></italic>
###xml 402 407 402 407 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Hmox1</italic>
###xml 407 410 407 410 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/+</sup>
###xml 417 425 417 425 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig1">Fig. 1 D</xref>
###xml 63 67 <span type="species:ncbi:10090">mice</span>
###xml 90 94 <span type="species:ncbi:10090">mice</span>
###xml 286 290 <span type="species:ncbi:10090">mice</span>
###xml 411 415 <span type="species:ncbi:10090">mice</span>
###xml 428 432 <span type="species:ncbi:10090">Mice</span>
###xml 633 637 <span type="species:ncbi:10090">mice</span>
For myeloid-restricted ablation of HO-1, we crossed Hmox1FL/FL mice with LysM-Cre knockin mice. The LysM-Cre transgene mediates excision of loxP-flanked sequences in macrophages and granulocytes (22). Immunoblot analysis of TEPM extracts from LysMCre/+Hmox1FL/FL and LysMCre/+Hmox1D/FL mice demonstrated efficient ablation of HO-1 at the protein level as compared with TEPM extracts from Hmox1FL/FL or Hmox1+/+ mice (Fig. 1 D). Mice with myeloid-restricted HO-1 deficiency were born at the expected Mendelian ratio, were viable and fertile, and did not show apparent abnormalities. Histological analysis of organ sections from these mice did not demonstrate any gross morphological defects (unpublished data).
###end p 9
###begin title 10
HO-1 is not required for NF-kappaB and MAPK activation in response to TLR4 and TLR3 stimulation
###end title 10
###begin p 11
###xml 97 101 97 101 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LysM</italic>
###xml 101 104 101 104 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Cre</italic>
###xml 101 106 101 106 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><italic>Cre</italic>/+</sup>
###xml 106 111 106 111 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Hmox1</italic>
###xml 111 116 111 116 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FL/FL</italic>
###xml 111 116 111 116 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><italic>FL/FL</italic></sup>
###xml 122 126 122 126 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">M-KO</sup>
###xml 137 142 137 142 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FL/FL</sup>
###xml 132 142 132 142 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Hmox1<sup>FL/FL</sup></italic>
###xml 395 399 387 391 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">M-KO</sup>
###xml 566 570 558 562 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">M-KO</sup>
###xml 618 620 610 612 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">KO</sup>
###xml 153 157 <span type="species:ncbi:10090">mice</span>
###xml 621 625 <span type="species:ncbi:10090">mice</span>
To investigate innate immune defects in the absence of myeloid HO-1, peritoneal macrophages from LysMCre/+Hmox1FL/FL (HO-1M-KO) and Hmox1FL/FL (control) mice were stimulated in vitro with LPS or polyI:C, and phosphorylation of the NF-kappaB and MAPKs was examined. Activation of IKK1, IKK2, IkappaB, ERK1/2, JNK2, and p38 occurred to the same extent and with similar kinetics in control and HO-1M-KO macrophages in response to LPS () or polyI:C (Fig. S1 B). Moreover, no significant differences were observed in the production of TNF or IL-6 between control and HO-1M-KO macrophages or BM macrophages (BMDMs) from HO-1KO mice in response to LPS or polyI:C (Fig. S1, C-E). Collectively, these results suggest that HO-1 is not required for TLR3- and TLR4-mediated activation of the NF-kappaB or AP-1 pathways in macrophages.
###end p 11
###begin title 12
HO-1 deficiency impairs IFN-beta production induced by TLR4 or TLR3 and is required for the induction of primary IRF3 target genes in macrophages
###end title 12
###begin p 13
###xml 200 202 200 202 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib23">23</xref>
###xml 204 206 204 206 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib24">24</xref>
###xml 286 288 286 288 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib25">25</xref>
###xml 548 556 545 553 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig2">Fig. 2 A</xref>
###xml 677 685 671 679 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig2">Fig. 2 A</xref>
###xml 1100 1108 1094 1102 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig2">Fig. 2 B</xref>
###xml 1528 1532 1522 1526 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">M-KO</sup>
###xml 1925 1927 1910 1912 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib17">17</xref>
###xml 1533 1537 <span type="species:ncbi:10090">mice</span>
TLR3 and TLR4 signals induce gene transcription through DNA motifs, designated IFN-stimulated response elements (ISREs), found in promoters of genes that bind the IRF family of transcription factors (23, 24). These include early inflammatory genes, antiviral cytokines, and chemokines (25). We therefore examined whether HO-1 is required for the induction of these genes in response to dsRNA or LPS. After being stimulated with polyI:C, HO-1-deficient macrophages showed significantly attenuated IFN-beta production as compared with control cells (Fig. 2 A). Similarly, the amount of IFN-beta produced after LPS stimulation of HO-1-deficient macrophages was severely impaired (Fig. 2 A). We also examined whether HO-1 is required for the induction of chemokine genes encoding RANTES, IP-10, MCP-1, MIP-1a, and MIP-1b in macrophages. HO-1-deficient and control TEPMs were stimulated with LPS for several time points and mRNA expression of all five chemokine genes was analyzed. Induction of genes encoding RANTES, IP-10, and MCP-1 was severely impaired in HO-1-deficient TEPMs compared with controls (Fig. 2 B). To eliminate the possibility that the observed defects are caused by an intrinsic defect in the expression of LPS/dsRNA receptors, we also analyzed induction of all known LPS/dsRNA receptors in response to LPS or polyI:C stimulation. Induction of genes encoding TLR4, TLR3, RIG-I, MDA5, and protein kinase regulated by RNA (PKR) occurred to the same extent in LPS- or polyI:C-treated macrophages from control and HO-1M-KO mice (). Finally, we questioned whether expression of IFN-beta and HO-1 in macrophages trigger a "positive feedback loop" in which IFN-beta (or TLR3 and/or TLR4 stimulation) up-regulates HO-1 and HO-1 mediates IFN-beta expression. A similar phenomenon has been shown to mediate the antiinflammatory effect of IL-10 in macrophages in which IL-10 up-regulates HO-1 and HO-1 up-regulates IL-10 (17). To address this, we stimulated macrophages with LPS, polyI:C, and rIFN-beta, and we analyzed HO-1 protein expression by Western blotting. We found that LPS treatment led to a significant induction of HO-1 protein expression, whereas polyI:C or rIFN-beta did not induce HO-1 at all time points tested ().
###end p 13
###begin p 14
###xml 0 79 0 76 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Defective IRF3 signaling and IFN-&#946; production in HO-1&#8211;deficient macrophages.</bold>
###xml 147 148 141 142 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 162 164 156 158 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">KO</sup>
###xml 166 167 160 161 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 393 394 385 386 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 407 411 399 403 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">M-KO</sup>
###xml 413 414 405 406 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 494 498 482 486 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">M-KO</sup>
###xml 173 177 <span type="species:ncbi:10090">mice</span>
###xml 420 424 <span type="species:ncbi:10090">mice</span>
Defective IRF3 signaling and IFN-beta production in HO-1-deficient macrophages. (A) ELISA of IFN-beta production from BMDMs prepared from control (n = 3) and HO-1KO (n = 3) mice; cells were left untreated or stimulated for 24 h with polyI:C or LPS. Data are means +/- SD of three independent experiments. (B) Chemokine mRNA was analyzed by Northern blotting in LPS-treated TEPMs from control (n = 3) or HO-1M-KO (n = 3) mice. (C) Nuclear extracts (5 microg) from polyI:C-treated control or HO-1M-KO TEPMs were submitted to EMSA using an NF-kappaB-specific probe. (D) The same nuclear extracts were submitted to EMSA using the ISG15 ISRE. IRF3 associated with coactivators and IRF3 dimers are shown. To confirm binding specificity, 200-fold (lane 13) excess of unlabeled (cold) ISREs or NF-kappaB probes were present during the binding reaction. In C and D, c represents a 200-fold excess of the unlabeled (cold) ISRE probe present during the binding reaction to confirm binding specificity. (E) Control and HO-1-deficient TEPMs were stimulated with polyI:C for the indicated time points, and WCEs were blotted with antibodies to p-IRF3 and IRF3 as loading control. (F) Control and HO-1-deficient TEPMs were stimulated with heme and/or polyI:C, and cell lysates were immunoprecipitated with anti-IRF3 antibody or isotype control. The precipitates were resolved on SDS-PAGE and transferred onto a membrane. The blot was probed with anti-HO-1 antibody. (G) Kinase activity of TBK-1 was measured on WCEs from control and HO-1-deficient TEPMs by immune complex kinase assay (KA) using GST-IRF3 as substrate. For immunoblotting (IB), the top part of the gel was probed with a TBK-1 antibody to confirm equal amounts of the immunoprecipitated kinase. All experiments were performed at least two times. Black lines indicate that intervening lanes have been spliced out.
###end p 14
###begin title 15
HO-1 interacts with IRF3 and is required for its activation
###end title 15
###begin p 16
###xml 254 256 248 250 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib26">26</xref>
###xml 315 317 305 307 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib27">27</xref>
###xml 453 455 440 442 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib25">25</xref>
###xml 457 459 444 446 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib28">28</xref>
###xml 712 716 695 699 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">M-KO</sup>
###xml 1002 1010 977 985 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig2">Fig. 2 C</xref>
###xml 1174 1179 1149 1154 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Isg15</italic>
###xml 1417 1419 1392 1394 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib29">29</xref>
###xml 1472 1480 1447 1455 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig2">Fig. 2 D</xref>
###xml 1740 1742 1715 1717 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib29">29</xref>
###xml 1855 1859 1830 1834 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">M-KO</sup>
###xml 2116 2124 2091 2099 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig2">Fig. 2 E</xref>
###xml 2501 2505 2476 2480 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">M-KO</sup>
###xml 2724 2732 2699 2707 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig2">Fig. 2 F</xref>
###xml 3403 3411 3375 3383 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig2">Fig. 2 G</xref>
###xml 717 721 <span type="species:ncbi:10090">mice</span>
###xml 1860 1864 <span type="species:ncbi:10090">mice</span>
A common feature of the IFN-beta, RANTES, and IP-10 genes is that multiple transcriptional regulatory elements are required for their activation. For example, IFN-beta gene expression requires the coordinate activation of the transcription factors IRF3 (26), NF-kappaB, and activating transcription factor 2/c-Jun (27). Various studies have established an essential role for IRF3 in LPS- and polyI:C-induced IFN-beta, RANTES, and IP-10 gene expression (25, 28). We therefore sought to examine whether HO-1 deficiency interferes with the activation of these transcription factors. To determine NF-kappaB activity in the absence of HO-1 in polyI:C-induced gene expression, we stimulated TEPMs from control and HO-1M-KO mice with polyI:C for several time points, and nuclear extracts were analyzed for DNA binding activity by EMSA using a probe specific for the kappaB site. No significant difference was observed in the kinetics of NF-kappaB binding in HO-1-deficient extracts as compared with controls (Fig. 2 C), a finding that is in agreement with the results described in Fig. S1 B. We next assayed IRF3 DNA binding by EMSA using the IFN- and virus-inducible ISREs of the Isg15 gene. Stimulation of control macrophages with polyI:C led to the detection of two complexes. The faster migrating complex corresponded to IRF3, whereas the slower complexes corresponded to IRF3 associated with the p300/CBP coactivators (29). In the absence of HO-1, IRF3 binding was reduced (Fig. 2 D). IRF3 primarily exists in two forms, a monomeric form that shuttles between the cytoplasm and the nucleus with a dominance of export versus import, and a dimeric form that results from its phosphorylation at the C terminus and is sequestered in the nucleus (29). To investigate whether HO-1 is involved in the phosphorylation of IRF3, we treated TEPMs from control and HO-1M-KO mice with polyI:C, and phosphorylation of IRF3 was detected by Western blotting using an antibody that specifically detects the phosphorylated form of IRF3. We found that activation of IRF3 was reduced in HO-1-deficient macrophages compared with controls (Fig. 2 E). In addition, IRF3 nuclear accumulation was detected by immunofluoresence. Consistent with the Western blotting and DNA-binding experiments, IRF3 nuclear accumulation was significantly reduced in macrophages lacking HO-1 (). To investigate whether HO-1 interacts with IRF3, we performed coimmunoprecipitation experiments using whole-cell extracts (WCEs) from control and HO-1M-KO macrophages treated with hemin to induce endogenous HO-1 protein and/or polyI:C. HO-1 immunoblot analysis on cell lysates that were immunoprecipitated with an anti-IRF3 antibody revealed that HO-1 interacts with IRF3 (Fig. 2 F). To determine whether HO-1 is also required for IRF7 activation, a transcription factor that also regulates IFN-beta production, we stimulated control and HO-1-deficient macrophages with polyI:C and analyzed IRF7 mRNA induction. We found that IRF7 induction was similar in control and HO-1-deficient macrophages in response to polyI:C stimulation (Fig. S2). In addition, to determine whether lack of HO-1 affects the kinase activity of TBK-1, we performed a TBK-1 assay using cytoplasmic extracts from control and HO-1-deficient macrophages treated with polyI:C. We found that TBK-1 activity was similar in extracts derived from control and HO-1-deficient macrophages (Fig. 2 G). Collectively, these results show that HO-1 specifically interacts with IRF3 and affects its phosphorylation and subsequent nuclear translocation without affecting TBK-1 activity.
###end p 16
###begin title 17
HO-1 is required for in vivo innate immune responses to TLR3
###end title 17
###begin p 18
###xml 31 47 31 47 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">L. monocytogenes</italic>
###xml 160 162 157 159 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib30">30</xref>
###xml 164 166 161 163 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib31">31</xref>
###xml 240 256 237 253 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">L. monocytogenes</italic>
###xml 268 270 265 267 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib30">30</xref>
###xml 419 435 416 432 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">L. monocytogenes</italic>
###xml 447 449 444 446 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib30">30</xref>
###xml 451 453 448 450 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib32">32</xref>
###xml 471 477 468 474 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig2">Fig. 2</xref>
###xml 687 703 678 694 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">L. monocytogenes</italic>
###xml 755 759 746 750 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">M-KO</sup>
###xml 790 806 781 797 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">L. monocytogenes</italic>
###xml 850 858 841 849 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig3">Fig. 3 A</xref>
###xml 1058 1074 1049 1065 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">L. monocytogenes</italic>
###xml 1156 1160 1147 1151 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">M-KO</sup>
###xml 1190 1198 1181 1189 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig3">Fig. 3 A</xref>
###xml 1298 1302 1289 1293 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">M-KO</sup>
###xml 1409 1425 1400 1416 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">L. monocytogenes</italic>
###xml 1552 1568 1543 1559 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">L. monocytogenes</italic>
###xml 1576 1593 1567 1584 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig3">Fig. 3 B, a and c</xref>
###xml 1650 1654 1641 1645 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">M-KO</sup>
###xml 1747 1764 1738 1755 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig3">Fig. 3 B, b and d</xref>
###xml 1846 1862 1834 1850 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">L. monocytogenes</italic>
###xml 1884 1886 1872 1874 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib31">31</xref>
###xml 1911 1915 1899 1903 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IRF3</italic>
###xml 1919 1925 1907 1913 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IFNAR1</italic>
###xml 1948 1964 1936 1952 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">L. monocytogenes</italic>
###xml 2050 2052 2038 2040 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib30">30</xref>
###xml 2102 2106 2090 2094 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">M-KO</sup>
###xml 2211 2227 2199 2215 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">L. monocytogenes</italic>
###xml 2446 2454 2434 2442 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig3">Fig. 3 C</xref>
###xml 2576 2592 2561 2577 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">L. monocytogenes</italic>
###xml 2732 2740 2714 2722 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig3">Fig. 3 D</xref>
###xml 2877 2881 2856 2860 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">M-KO</sup>
###xml 2940 2956 2919 2935 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">L. monocytogenes</italic>
###xml 3065 3069 3041 3045 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">M-KO</sup>
###xml 3102 3110 3078 3086 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig3">Fig. 3 E</xref>
###xml 3219 3235 3192 3208 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">L. monocytogenes</italic>
###xml 31 47 <span type="species:ncbi:1639">L. monocytogenes</span>
###xml 240 256 <span type="species:ncbi:1639">L. monocytogenes</span>
###xml 419 435 <span type="species:ncbi:1639">L. monocytogenes</span>
###xml 629 633 <span type="species:ncbi:10090">mice</span>
###xml 687 703 <span type="species:ncbi:1639">L. monocytogenes</span>
###xml 760 764 <span type="species:ncbi:10090">mice</span>
###xml 790 806 <span type="species:ncbi:1639">L. monocytogenes</span>
###xml 816 820 <span type="species:ncbi:10090">mice</span>
###xml 956 960 <span type="species:ncbi:10090">mice</span>
###xml 1005 1009 <span type="species:ncbi:10090">mice</span>
###xml 1058 1074 <span type="species:ncbi:1639">L. monocytogenes</span>
###xml 1115 1119 <span type="species:ncbi:10090">mice</span>
###xml 1161 1165 <span type="species:ncbi:10090">mice</span>
###xml 1260 1264 <span type="species:ncbi:10090">mice</span>
###xml 1303 1307 <span type="species:ncbi:10090">mice</span>
###xml 1409 1425 <span type="species:ncbi:1639">L. monocytogenes</span>
###xml 1441 1445 <span type="species:ncbi:10090">mice</span>
###xml 1523 1527 <span type="species:ncbi:10090">mice</span>
###xml 1552 1568 <span type="species:ncbi:1639">L. monocytogenes</span>
###xml 1655 1659 <span type="species:ncbi:10090">mice</span>
###xml 1846 1862 <span type="species:ncbi:1639">L. monocytogenes</span>
###xml 1893 1897 <span type="species:ncbi:10090">mice</span>
###xml 1948 1964 <span type="species:ncbi:1639">L. monocytogenes</span>
###xml 2107 2111 <span type="species:ncbi:10090">mice</span>
###xml 2211 2227 <span type="species:ncbi:1639">L. monocytogenes</span>
###xml 2576 2592 <span type="species:ncbi:1639">L. monocytogenes</span>
###xml 2882 2886 <span type="species:ncbi:10090">mice</span>
###xml 2940 2956 <span type="species:ncbi:1639">L. monocytogenes</span>
###xml 3070 3074 <span type="species:ncbi:10090">mice</span>
###xml 3219 3235 <span type="species:ncbi:1639">L. monocytogenes</span>
Recent studies have shown that L. monocytogenes can induce IFN-beta once inside the cytoplasm of infected macrophages through the TBK-1-IRF3 signaling pathway (30, 31). IRF3-mediated induction of type I IFNs results in enhanced severity of L. monocytogenes infection (30). Furthermore, it has been shown that intravenous injection of polyI:C results in strong induction of type I IFNs that enhance pathogenicity during L. monocytogenes infection (30, 32). We have shown (Fig. 2) that HO-1-deficient macrophages have defective IRF3 signaling and IFN-beta production, and we sought to determine whether HO-1 deficiency can protect mice from IFN-beta-mediated sensitization to death during L. monocytogenes infection. We initially challenged control and HO-1M-KO mice with a sublethal dose of L. monocytogenes, and all mice remained healthy and viable (Fig. 3 A). Likewise, administration of polyI:C alone did not appear to influence the health status of the mice by day 14 (unpublished data). However, when mice were given a combination of a sublethal dose of L. monocytogenes along with polyI:C, only 10% of control mice remained viable, whereas 70% of HO-1M-KO mice survived the infection (Fig. 3 A). When a lower dose of polyI:C was used, only 40% of control mice remained viable, whereas all HO-1M-KO mice survived the infection (unpublished data). Histological analysis of control livers from polyI:C- and L. monocytogenes-coadministered mice revealed multiple parenchymal abscesses as compared with livers from control mice that were infected with L. monocytogenes alone (Fig. 3 B, a and c). Consistent with the survival studies, livers from HO-1M-KO mice with or without coadministration of polyI:C were relatively clear of tissue abscesses (Fig. 3 B, b and d). Infection-borne IFN-beta plays an important role in sensitizing macrophages to L. monocytogenes-mediated cell death (31), and mice deficient in IRF3 or IFNAR1 are more resistant to L. monocytogenes infection because their splenocytes do not succumb to type I IFN-mediated apoptosis (30). To determine whether increased survival of HO-1M-KO mice is caused by reduced macrophage apoptosis, we infected control and HO-1-deficient macrophages with L. monocytogenes at different multiplicities of infection (MOIs) in the presence of polyI:C and measured cell death 24 h later. We found that 80% of HO-1-deficient cells survived the infection compared with 30% of control macrophages (Fig. 3 C). We also measured IFN-beta production in culture supernatants from control and HO-1-deficient macrophages infected with L. monocytogenes in the presence of polyI:C. HO-1-deficient macrophages showed significantly attenuated IFN-beta production as compared with control cells (Fig. 3 D), and this correlated with susceptibility to cell death. Finally, we measured IFN-beta production in serum samples from control and HO-1M-KO mice challenged with a combination of a sublethal dose of L. monocytogenes along with polyI:C. In agreement with these in vitro data, IFN-beta production was severely impaired in HO-1M-KO mice as compared with controls (Fig. 3 E). Collectively, these data suggest a major contribution of HO-1 to TLR3/IFN-beta-mediated cell death during L. monocytogenes infections.
###end p 18
###begin p 19
###xml 0 105 0 105 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HO-1 in macrophages is required for the generation of immune responses to bacterial and viral infections.</bold>
###xml 126 130 126 130 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">M-KO</sup>
###xml 171 172 171 172 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5</sup>
###xml 177 193 177 193 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">L. monocytogenes</italic>
###xml 221 222 221 222 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5</sup>
###xml 227 243 227 243 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">L. monocytogenes</italic>
###xml 445 449 439 443 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">M-KO</sup>
###xml 485 486 479 480 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5</sup>
###xml 491 507 485 501 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">L. monocytogenes</italic>
###xml 765 766 751 752 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 780 784 766 770 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">M-KO</sup>
###xml 786 787 772 773 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 817 833 803 819 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">L. monocytogenes</italic>
###xml 865 881 851 867 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">L. monocytogenes</italic>
###xml 1219 1223 1198 1202 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">M-KO</sup>
###xml 1250 1251 1229 1230 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5</sup>
###xml 1256 1272 1235 1251 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">L. monocytogenes</italic>
###xml 1300 1301 1279 1280 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5</sup>
###xml 1306 1322 1285 1301 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">L. monocytogenes</italic>
###xml 1521 1522 1491 1492 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 1536 1540 1506 1510 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">M-KO</sup>
###xml 1542 1543 1512 1513 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 1721 1722 1686 1687 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 1736 1740 1701 1705 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">M-KO</sup>
###xml 1742 1743 1707 1708 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 131 135 <span type="species:ncbi:10090">mice</span>
###xml 177 193 <span type="species:ncbi:1639">L. monocytogenes</span>
###xml 227 243 <span type="species:ncbi:1639">L. monocytogenes</span>
###xml 388 392 <span type="species:ncbi:10090">mice</span>
###xml 450 454 <span type="species:ncbi:10090">mice</span>
###xml 491 507 <span type="species:ncbi:1639">L. monocytogenes</span>
###xml 697 701 <span type="species:ncbi:10090">mice</span>
###xml 793 797 <span type="species:ncbi:10090">mice</span>
###xml 817 833 <span type="species:ncbi:1639">L. monocytogenes</span>
###xml 865 881 <span type="species:ncbi:1639">L. monocytogenes</span>
###xml 1069 1073 <span type="species:ncbi:10090">mice</span>
###xml 1182 1186 <span type="species:ncbi:10090">mice</span>
###xml 1224 1228 <span type="species:ncbi:10090">mice</span>
###xml 1256 1272 <span type="species:ncbi:1639">L. monocytogenes</span>
###xml 1306 1322 <span type="species:ncbi:1639">L. monocytogenes</span>
###xml 1480 1484 <span type="species:ncbi:10090">mice</span>
###xml 1549 1553 <span type="species:ncbi:10090">mice</span>
###xml 1573 1576 <span type="species:ncbi:11191">SeV</span>
###xml 1749 1753 <span type="species:ncbi:10090">mice</span>
###xml 1773 1776 <span type="species:ncbi:11191">SeV</span>
HO-1 in macrophages is required for the generation of immune responses to bacterial and viral infections. (A) Control and HO-1M-KO mice were infected intravenously with 105 CFU L. monocytogenes or with a combination of 105 CFU L. monocytogenes and 200 microg polyI:C, and viability was assayed daily for 14 d. Data are representative of two independent experiments (means +/- SEM of nine mice per group). (B) Liver sections from control and HO-1M-KO mice infected intravenously with 105 CFU L. monocytogenes either in the absence (a and b) or presence (c and d) of 100 microg polyI:C were stained with H&E to assess inflammation. Representative sections from two independent experiments with five mice per group are shown. Bars, 100 microM. (C) TEPMs from control (n = 3) and HO-1M-KO (n = 3) mice were infected with L. monocytogenes at different MOIs (circles) or L. monocytogenes and polyI:C (triangles) as indicated, and cell survival was measured by crystal violet staining after 24 h. Data are representative of two independent experiments (means +/- SEM of three mice per group). (D) IFN-beta production was measured in supernatants from cultures in C (means +/- SEM of three mice per group). (E) Control and HO-1M-KO mice were infected with 105 CFU L. monocytogenes or with a combination of 105 CFU L. monocytogenes and 200 microg polyI:C, and IFN-beta was measured in sera collected 24 h later. Data are representative of two independent experiments (means +/- SEM of six mice per group). (F) TEPMs from control (n = 3) and HO-1M-KO (n = 3) mice were infected with SeV, and IFN-beta production was measured in supernatants after 24 h. Data are means +/- SD of two independent experiments. (G) TEPMs from control (n = 3) and HO-1M-KO (n = 3) mice were infected with SeV for the indicated time points, and WCEs were probed for p-IRF3 and IRF3 as a loading control. Representative data from two independent experiments are shown. n.d., none detected.
###end p 19
###begin title 20
HO-1 is required for IFN-beta production in response to virus infection
###end title 20
###begin p 21
###xml 150 154 150 154 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">M-KO</sup>
###xml 323 324 323 324 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib8">8</xref>
###xml 466 474 463 471 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig3">Fig. 3 F</xref>
###xml 636 644 633 641 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig3">Fig. 3 G</xref>
###xml 155 159 <span type="species:ncbi:10090">mice</span>
###xml 165 168 <span type="species:ncbi:11191">SeV</span>
###xml 210 213 <span type="species:ncbi:11191">SeV</span>
###xml 430 433 <span type="species:ncbi:11191">SeV</span>
###xml 584 587 <span type="species:ncbi:11191">SeV</span>
###xml 754 757 <span type="species:ncbi:11191">SeV</span>
To gain insights into the biological relevance of macrophage HO-1 in virus infection-mediated responses, we infected macrophages from control and HO-1M-KO mice with SeV. Detection of paramyxoviruses, including SeV, has been attributed mainly to the RNA helicase RIG-I and, to a lesser extent, the RIG-I-like receptor MDA5 (8). We found that production of IFN-beta was severely impaired in HO-1-deficient macrophages infected with SeV as compared with control cells (Fig. 3 F). In addition, HO-1-deficient macrophages displayed severely impaired phosphorylation of IRF3 in response to SeV infection as compared with control macrophages (Fig. 3 G). Collectively, these results indicate that HO-1 is indispensable for triggering antiviral responses against SeV infection.
###end p 21
###begin title 22
Myeloid-specific ablation of HO-1 exacerbates EAE and is not suppressed by polyI:C-mediated IFN-beta production
###end title 22
###begin p 23
###xml 65 67 62 64 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib33">33</xref>
###xml 69 71 66 68 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib34">34</xref>
###xml 148 150 142 144 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib35">35</xref>
###xml 312 314 306 308 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib20">20</xref>
###xml 398 403 392 397 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">35-55</sub>
###xml 418 422 412 416 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">M-KO</sup>
###xml 543 551 537 545 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig4">Fig. 4 A</xref>
###xml 743 747 737 741 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LysM</italic>
###xml 747 750 741 744 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Cre</italic>
###xml 747 752 741 746 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><italic>Cre</italic>/+</sup>
###xml 850 854 844 848 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LysM</italic>
###xml 974 978 968 972 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">M-KO</sup>
###xml 1181 1185 1175 1179 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">M-KO</sup>
###xml 1383 1387 1373 1377 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">M-KO</sup>
###xml 1572 1576 1562 1566 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">M-KO</sup>
###xml 1649 1653 1639 1643 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">M-KO</sup>
###xml 1859 1863 1845 1849 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">M-KO</sup>
###xml 1918 1922 1904 1908 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">M-KO</sup>
###xml 2046 2054 2032 2040 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig4">Fig. 4 B</xref>
###xml 2128 2132 2114 2118 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">M-KO</sup>
###xml 2196 2197 2182 2183 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 2205 2206 2191 2192 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 2270 2278 2256 2264 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig4">Fig. 4 C</xref>
###xml 2316 2320 2302 2306 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">high</sup>
###xml 2326 2327 2312 2313 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 2330 2331 2316 2317 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;</sup>
###xml 2386 2387 2372 2373 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">b</sup>
###xml 2396 2397 2382 2383 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">b</sup>
###xml 2399 2407 2385 2393 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig4">Fig. 4 D</xref>
###xml 2454 2458 2440 2444 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">M-KO</sup>
###xml 2534 2535 2520 2521 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 2608 2609 2590 2591 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 2619 2627 2601 2609 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig4">Fig. 4 E</xref>
###xml 2893 2895 2868 2870 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib36">36</xref>
###xml 3152 3156 3121 3125 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">M-KO</sup>
###xml 3244 3248 3210 3214 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">M-KO</sup>
###xml 3547 3551 3509 3513 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">M-KO</sup>
###xml 3626 3630 3588 3592 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">M-KO</sup>
###xml 3637 3652 3599 3614 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig5">Fig. 5, A and B</xref>
###xml 3799 3803 3758 3762 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">M-KO</sup>
###xml 4028 4032 3984 3988 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">M-KO</sup>
###xml 4095 4099 4048 4052 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">M-KO</sup>
###xml 4134 4142 4087 4095 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig5">Fig. 5 C</xref>
###xml 4413 4417 4366 4370 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">M-KO</sup>
###xml 121 125 <span type="species:ncbi:10090">mice</span>
###xml 423 427 <span type="species:ncbi:10090">mice</span>
###xml 753 757 <span type="species:ncbi:10090">mice</span>
###xml 991 995 <span type="species:ncbi:10090">mice</span>
###xml 1198 1202 <span type="species:ncbi:10090">mice</span>
###xml 1388 1392 <span type="species:ncbi:10090">mice</span>
###xml 1577 1581 <span type="species:ncbi:10090">mice</span>
###xml 1654 1658 <span type="species:ncbi:10090">mice</span>
###xml 1876 1880 <span type="species:ncbi:10090">mice</span>
###xml 1923 1927 <span type="species:ncbi:10090">mice</span>
###xml 2040 2044 <span type="species:ncbi:10090">mice</span>
###xml 2133 2137 <span type="species:ncbi:10090">mice</span>
###xml 2264 2268 <span type="species:ncbi:10090">mice</span>
###xml 2459 2463 <span type="species:ncbi:10090">mice</span>
###xml 3157 3161 <span type="species:ncbi:10090">mice</span>
###xml 3261 3265 <span type="species:ncbi:10090">mice</span>
###xml 3303 3308 <span type="species:ncbi:10090">mouse</span>
###xml 3440 3444 <span type="species:ncbi:10090">mice</span>
###xml 3504 3508 <span type="species:ncbi:10090">mice</span>
###xml 3552 3556 <span type="species:ncbi:10090">mice</span>
###xml 3631 3635 <span type="species:ncbi:10090">mice</span>
###xml 3769 3773 <span type="species:ncbi:10090">mice</span>
###xml 3804 3808 <span type="species:ncbi:10090">mice</span>
###xml 4033 4037 <span type="species:ncbi:10090">mice</span>
###xml 4100 4104 <span type="species:ncbi:10090">mice</span>
###xml 4418 4422 <span type="species:ncbi:10090">mice</span>
Multiple sclerosis is one of the diseases treated with IFN-beta (33, 34), and recent studies show that IFN-beta knockout mice have exacerbated EAE (35). More recent reports have also suggested a role for HO-1 in EAE, although the HO-1-mediated protective effects and their cellular basis remain largely unknown (20). When immunized with the encephalitogenic myelin oligodendrocyte glycoprotein (MOG35-55) peptide, HO-1M-KO mice developed significantly more severe and chronic EAE with higher incidence compared with their control littermates (Fig. 4 A). Myeloid HO-1 deficiency did not affect the timing of disease onset but predominantly affected the severity and chronicity of EAE. Moreover, no differences in EAE severity between immunized LysMCre/+ mice and WT littermates were observed (), suggesting that expression of the Cre transgene in the LysM locus does not affect the course of EAE. To examine whether differences in EAE susceptibility and severity between HO-1M-KO and control mice lies in the priming of encephalitogenic T cells, we examined antigen-specific T cell responses in popliteal lymph nodes 8-10 d after infection. No differences were observed between HO-1M-KO and control mice regarding the capacity of T cells to proliferate () or to produce IFN-gamma and IL-4 (not depicted) in response to recall antigen. We next asked whether disease progression in HO-1M-KO mice may be caused by sustained autoreactivity of antigen-specific T cells. To address this, we examined the activation and differentiation of myelin-specific T cells in immunized HO-1M-KO mice during the late relapse and remission stages. Splenocytes from HO-1M-KO mice showed a fourfold higher proliferation compared with control cells and produced much higher levels of IFN-gamma and TNF (Fig. S6, B-D) in response to MOG. Histological analysis of spinal cords of HO-1M-KO and control mice 25 d after infection showed that HO-1M-KO mice had significantly more cellular infiltration and demyelination throughout the spinal cord compared with control mice (Fig. 4 B). Flow cytometry analysis of the immune cell infiltrates showed that HO-1M-KO mice had increased numbers of inflammatory cells, including CD4+ and CD8+ T cells, macrophages, and granulocytes, than did control mice (Fig. 4 C and ). Infiltrating macrophages (CD45high CD11b+Gr1-) showed increased expression of CD40, CD80, CD86, H-2Kb, and I-Ab (Fig. 4 D) as compared with controls. In the CNS of HO-1M-KO mice, we observed a fivefold increase in the numbers of IL-17-producing CD4+ T cells and a twofold increase in the numbers of IFN-gamma-producing CD4+ T cells (Fig. 4 E) with an IL-17/IFN-gamma ratio of >2:1. Recent studies show that a preferential activation of the MyD88-independent, type I IFN-inducing TLR pathway has immunomodulatory potential in EAE and that disease suppression is associated with increased levels of IFN-beta (36). Touil et al. performed in vivo neutralization experiments and showed that EAE protection by polyI:C was reversed by an anti-IFN-beta antibody, indicating a role for IFN-beta in mediating this effect of polyI:C. To test whether exacerbation of EAE in HO-1M-KO mice was associated with defective IFN-beta production from macrophages, immunized HO-1M-KO and control mice were administered polyI:C (30 microg/mouse/day) or PBS during the induction phase of EAE (days 5 and 8 after infection). Clinical signs of disease were suppressed in control mice that received polyI:C as compared with PBS-treated control mice. On the contrary, polyI:C-treated HO-1M-KO mice developed severe and chronic EAE that was similar to PBS-treated HO-1M-KO mice (Fig. 5, A and B). We then asked whether treatment with rIFN-beta can inhibit the clinical symptoms of EAE in myeloid HO-1-deficient mice. For this, immunized HO-1M-KO mice were administered polyI:C and were treated with PBS or rIFN-beta (200,000 IU/day) starting from day 9 after infection and continuing over a period of 14 d. Clinical signs of disease were significantly suppressed in HO-1M-KO mice that received polyI:C and rIFN-beta as compared with HO-1M-KO mice that received polyI:C alone (Fig. 5 C). Collectively, these data show that absence of myeloid HO-1 exacerbates EAE characterized by enhanced infiltration of macrophages and Th17 cells, and a nonregressing myelin-specific T cell reactivity. Furthermore, we showed that regulation of autoimmune disease in HO-1M-KO mice critically depends on IFN-beta production, demonstrating an essential requirement for HO-1 in this pathway.
###end p 23
###begin p 24
###xml 0 52 0 52 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Macrophage-restricted ablation of HO-1 augments EAE.</bold>
###xml 75 79 75 79 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">M-KO</sup>
###xml 81 82 81 82 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 112 113 112 113 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 304 308 302 306 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">M-KO</sup>
###xml 585 586 579 580 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 600 604 594 598 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">M-KO</sup>
###xml 606 607 600 601 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 922 926 916 920 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">M-KO</sup>
###xml 988 989 982 983 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 1003 1007 997 1001 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">M-KO</sup>
###xml 1026 1027 1020 1021 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 1092 1093 1086 1087 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">b</sup>
###xml 1102 1103 1096 1097 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">b</sup>
###xml 1141 1142 1135 1136 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 1156 1160 1150 1154 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">M-KO</sup>
###xml 1162 1163 1156 1157 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 1241 1242 1235 1236 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1442 1443 1432 1433 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1603 1607 1585 1589 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">M-KO</sup>
###xml 119 123 <span type="species:ncbi:10090">mice</span>
###xml 234 238 <span type="species:ncbi:10090">mice</span>
###xml 317 321 <span type="species:ncbi:10090">mice</span>
###xml 487 491 <span type="species:ncbi:10090">mice</span>
###xml 613 617 <span type="species:ncbi:10090">mice</span>
###xml 927 931 <span type="species:ncbi:10090">mice</span>
###xml 1033 1037 <span type="species:ncbi:10090">mice</span>
###xml 1169 1173 <span type="species:ncbi:10090">mice</span>
###xml 1608 1612 <span type="species:ncbi:10090">mice</span>
Macrophage-restricted ablation of HO-1 augments EAE. (A) Mean score of HO-1M-KO (n = 9) and littermate control (n = 9) mice at each measured time point. Results are representative of three different experiments (means +/- SEM of nine mice per group). (B) Spinal cord sections from control (left) and HO-1M-KO (right) mice were stained with H&E to assess inflammation (top) and with LFB (bottom) to assess demyelination. Representative sections from two independent experiments with four mice per group are shown. Bars, 100 microM. (C) Immune cell infiltration into the CNS of control (n = 3) and HO-1M-KO (n = 3) mice. Infiltrates were stained with antibodies to CD45, CD11b, CD4, CD8, B220, and Gr-1 (R1 and R2 indicate gated areas). Numbers in quadrants indicate the percentages of cells in each. Data are representative of three independent experiments. (D) Co-stimulatory and MHC molecule expression in the CNS of HO-1M-KO mice. Immune cell infiltrates of control (shaded histograms; n = 4) and HO-1M-KO (open histograms; n = 4) mice were stained with antibodies to CD40, CD80, CD86, H-2Kb, and I-Ab. (E) Spinal cord cells from control (n = 3) and HO-1M-KO (n = 3) mice were harvested 25 d after infection, and the percentage of live CD4+ T cells that express intracellular IFN-gamma and IL-17 with or without stimulation (PMA/ionomycin) was measured by flow cytometry analysis. The numbers in each quadrant represent the frequency of CD4+ T cells expressing IFN-gamma and/or IL-17. Quantification and absolute numbers of IFN-gamma and IL-17-producing T cells in the spinal cords of control and HO-1M-KO mice are also shown. Data are representative of three independent experiments.
###end p 24
###begin p 25
###xml 67 71 67 71 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">M-KO</sup>
###xml 0 86 0 86 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Clinical and histological effects of polyI:C administration in HO-1<sup>M-KO</sup> mice with EAE.</bold>
###xml 100 101 100 101 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 115 119 115 119 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">M-KO</sup>
###xml 121 122 121 122 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 397 401 395 399 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">M-KO</sup>
###xml 620 624 614 618 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">M-KO</sup>
###xml 72 76 <span type="species:ncbi:10090">mice</span>
###xml 129 133 <span type="species:ncbi:10090">mice</span>
###xml 319 323 <span type="species:ncbi:10090">mice</span>
###xml 434 438 <span type="species:ncbi:10090">mice</span>
###xml 558 562 <span type="species:ncbi:10090">mice</span>
###xml 625 629 <span type="species:ncbi:10090">mice</span>
###xml 921 925 <span type="species:ncbi:10090">mice</span>
Clinical and histological effects of polyI:C administration in HO-1M-KO mice with EAE. (A) Control (n = 9) and HO-1M-KO (n = 10) mice were treated with intraperitoneal injections of polyI:C or PBS on days 5 and 8 after infection. Data are representative of three independent experiments (means +/- SEM of at least nine mice per group). (B) Spinal cord sections from immunized, polyI:C-treated HO-1M-KO (a and c) and control (b and d) mice 28 d after infection were stained with H&E and LFB. Representative sections from two independent experiments with five mice per group are shown. Bars, 100 microM. (C) Immunized HO-1M-KO mice were treated with intraperitoneal injections of polyI:C on days 5 and 8 after infection, and were either treated with PBS or with rhIFN-beta starting from day 9 after infection and continuing over a period of 14 d. Data are representative of two independent experiments (means +/- SEM of 10 mice per group).
###end p 25
###begin title 26
DISCUSSION
###end title 26
###begin p 27
###xml 79 81 79 81 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib37">37</xref>
###xml 83 85 83 85 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib38">38</xref>
###xml 664 666 664 666 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib39">39</xref>
###xml 722 724 722 724 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib40">40</xref>
###xml 921 923 921 923 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib16">16</xref>
###xml 925 927 925 927 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib41">41</xref>
###xml 1278 1280 1278 1280 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib17">17</xref>
HO-1 is known to be involved in a vast array of pathophysiological conditions (37, 38). HO-1 expression or CO administration mediate potent antiinflammatory effects in monocytes and/or macrophages, probably restraining these cells from inducing tissue injury and modulating their role in the initiation of immune responses. Several studies have shown the protective effects of the HO-1/CO system; CO suppresses the proinflammatory and promotes the antiinflammatory response of macrophages, a cell type that controls the balance of inflammation in many conditions. Macrophages stimulated with bacterial LPS produce several proinflammatory cytokines, including TNF (39), as well as antiinflammatory cytokines such as IL-10 (40). If macrophages overexpress HO-1 or are exposed to CO in vitro before stimulation with LPS, the proinflammatory response is markedly inhibited, whereas the antiinflammatory response is enhanced (16, 41). In addition, Lee and Chau identified a potential interplay between IL-10 and HO-1 in the inhibition of LPS-induced inflammatory responses and provided evidence that HO-1 mediates the antiinflammatory function of IL-10 both in vivo and in vitro, and that IL-10 and HO-1 activate a positive feedback circuit to amplify the antiinflammatory response (17).
###end p 27
###begin p 28
###xml 455 457 452 454 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib42">42</xref>
###xml 746 748 743 745 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib43">43</xref>
###xml 823 825 820 822 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib44">44</xref>
###xml 1517 1519 1514 1516 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib10">10</xref>
###xml 1913 1915 1907 1909 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib11">11</xref>
###xml 2319 2323 2309 2313 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">M-KO</sup>
###xml 2709 2715 2695 2701 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig6">Fig. 6</xref>
###xml 2324 2328 <span type="species:ncbi:10090">mice</span>
In this work, we have provided genetic evidence that identifies a novel function for myeloid HO-1 as an upstream mediator of the IRF3/IFN-beta response, orchestrating many subsequent processes central to innate as well as adaptive immune responses. Our data indicate that HO-1 forms a complex with IRF3 and is essential for IRF3 activation and subsequent gene expression in response to TLR3/TLR4 stimulation. Although HO-1 can bind to its isoenzyme HO-2 (42), no reports demonstrate binding of HO-1 to known transcriptions factors. A recent study by Lin et al. has shown that HO-1 is detected in the nucleus of cultured cells after exposure to hypoxia, and that HO-1 protein altered binding of transcription factors involved in oxidative stress (43). HO-1 is not a traditional transcription factor with DNA binding motifs (44); therefore, direct transcriptional activation is less likely to occur. However, HO-1 could bind to other proteins, serving as the non-DNA binding protein of a transcriptional factor complex, or could be a scaffold protein, acting as a chaperone for unstable client proteins and keeping them poised for activation. It remains to be determined how HO-1 modulates transcription factor activity and if modulation of these factors is mediated by HO-1 protein or its byproducts, such as CO. Recent reports have also suggested a role for CO in the regulation of TLR signaling pathways. CO treatment was shown to negatively control TLR signaling by inhibiting translocation of TLRs to lipid rafts (10). In the same study, although CO inhibited TLR4 signaling and subsequent IFN-beta production after LPS stimulation, it did not affect TLR3-dependent signaling in macrophages in response to polyI:C treatment. Therefore, it appears that the observed effects of CO on the TLR3 signaling pathway are independent of the HO-1 protein function. This is supported by the observation of Hegazi et al. (11) that CO inhibits the synergistic activation of IL-12 p40 and inducible nitric oxide synthase by LPS/IFN-gamma through selective inhibition of IRF8. The immunological effects of CO required HO-1, and in the absence of functional HO-1, the inhibitory action of CO on IRF8 and IL-12 p40 expression was lost. In agreement with this, we have not observed a defect in IRF8 activation in macrophages from HO-1M-KO mice in response to LPS/IFN-gamma (unpublished data). These results suggest that the products of the HO-1 pathway impart antiinflammatory effects via different modes of action and that HO-1 may have a cytoprotective role independent of its two major metabolic byproducts. Collectively, these findings reveal a multifaceted role for HO-1 in immune responses, presented schematically in Fig. 6; in response to bacterial or viral stimuli, HO-1 is required for early activation of the type I IFN-inducing pathway and subsequent development of antiviral or adaptive immunity. At a later time point, HO-1, through CO production, acts to inhibit the proinflammatory response and enhance the antiinflammatory effects of IL-10.
###end p 28
###begin p 29
###xml 0 96 0 96 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A proposed model implicating myeloid HO-1&#8211;mediated regulation of immune cytokines and responses.</bold>
A proposed model implicating myeloid HO-1-mediated regulation of immune cytokines and responses. Upon TLR4 stimulation, HO-1 is not required for the early phase MyD88- or TRIF-dependent activation of MAPKs and NF-kappaB but is required for the suppression of inflammatory responses at later time points. On the other hand, early phase activation of the TRIF-IRF3 and RIG-I-IRF3 pathways requires HO-1 for the production of antiviral cytokines, TLR3/4 primary response genes, and the development of adaptive immune responses.
###end p 29
###begin p 30
###xml 172 188 172 188 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">L. monocytogenes</italic>
###xml 232 234 232 234 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib30">30</xref>
###xml 318 334 318 334 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">L. monocytogenes</italic>
###xml 601 603 598 600 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib30">30</xref>
###xml 605 607 602 604 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib31">31</xref>
###xml 694 710 691 707 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">L. monocytogenes</italic>
###xml 1434 1436 1419 1421 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib45">45</xref>
###xml 1536 1538 1521 1523 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib46">46</xref>
###xml 1540 1542 1525 1527 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib47">47</xref>
###xml 1705 1709 1690 1694 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">M-KO</sup>
###xml 1751 1755 1733 1737 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">M-KO</sup>
###xml 164 168 <span type="species:ncbi:10090">mice</span>
###xml 172 188 <span type="species:ncbi:1639">L. monocytogenes</span>
###xml 318 334 <span type="species:ncbi:1639">L. monocytogenes</span>
###xml 625 629 <span type="species:ncbi:10090">mice</span>
###xml 694 710 <span type="species:ncbi:1639">L. monocytogenes</span>
###xml 964 968 <span type="species:ncbi:10090">mice</span>
###xml 1710 1714 <span type="species:ncbi:10090">mice</span>
###xml 1756 1760 <span type="species:ncbi:10090">mice</span>
The physiological significance of the HO-1-mediated type I IFN induction was shown using a bacterial/viral infection model in which polyI:C dramatically sensitizes mice to L. monocytogenes inoculation in an IFNAR1-dependent manner (30). Even though the complete mechanism by which type I IFNs inhibit host immunity to L. monocytogenes is likely complex because of the pleiotropic cellular effects mediated by these cytokines, there is evidence showing that IRF3-dependent production of IFN-beta by the infected macrophages induces apoptosis in neighboring cells and, possibly, macrophages themselves (30, 31). In accordance, mice with myeloid-specific HO-1 deficiency were resistant to polyI:C/L. monocytogenes infection, and this was associated with reduced IFN-beta production in vivo. In addition, we showed that HO-1 deficiency exacerbated an autoimmune condition that is dependant on endogenous IFN-beta production. Absence of myeloid HO-1 exacerbated EAE in mice, and this was associated with enhanced leukocyte accumulation within the CNS, including Th17 cells and nonregressing myelin-specific T cell responses. It was recently shown that activation of the TLR3-type I IFN-inducing pathway by polyI:C suppresses EAE through induction of endogenous IFN-beta. IFN-beta is used for the treatment of multiple sclerosis; its mechanisms of action include induction of IL-10, inhibition of the expansion of encephalitogenic T cells (45), reduced production of inflammatory cytokines, and reduction of blood-brain barrier permeability (46, 47). In the absence of myeloid HO-1, activation of the type I IFN-inducing pathway by polyI:C treatment did not suppress the development of disease in immunized HO-1M-KO mice. In contrast, rIFN-beta-treated HO-1M-KO mice displayed low clinical scores, suggesting that the protective effects of HO-1 are mediated through endogenous IFN-beta induction.
###end p 30
###begin p 31
###xml 362 364 362 364 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib37">37</xref>
In conclusion, our findings demonstrate a multilayered functioning of HO-1 in immunity and disease, with an early critical involvement of this molecule in IRF3-driven innate immune activation and with subsequent enzymatic activities that are known to confer cell and tissue protective antiinflammatory, antiapoptotic, antiproliferative, and antioxidant effects (37). Differential modulation of such enzymatic and/or signaling activities of HO-1 may hold clues for more effective therapeutic uses of this molecule in a range of immune pathologies.
###end p 31
###begin title 32
MATERIALS AND METHODS
###end title 32
###begin title 33

###end title 33
###begin title 34
###xml 14 19 14 19 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Hmox1</italic>
###xml 41 45 <span type="species:ncbi:10090">mice</span>
Generation of Hmox1 conditional knockout mice.
###end title 34
###begin p 35
###xml 30 35 30 35 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Hmox1</italic>
###xml 269 272 269 272 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">lox</italic>
###xml 356 361 356 361 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Hmox1</italic>
###xml 372 375 372 375 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Not</italic>
###xml 377 380 377 380 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Not</italic>
###xml 452 455 452 455 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Xho</italic>
###xml 457 460 457 460 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Spe</italic>
###xml 504 509 504 509 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Hmox1</italic>
###xml 540 543 540 543 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">lox</italic>
###xml 565 568 565 568 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Nhe</italic>
###xml 570 573 570 573 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Bam</italic>
###xml 1354 1356 1350 1352 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib21">21</xref>
###xml 24 29 <span type="species:ncbi:10090">mouse</span>
###xml 97 102 <span type="species:ncbi:9606">Human</span>
###xml 187 192 <span type="species:ncbi:10090">mouse</span>
###xml 1133 1137 <span type="species:ncbi:10090">mice</span>
###xml 1211 1215 <span type="species:ncbi:10090">mice</span>
###xml 1234 1238 <span type="species:ncbi:10090">mice</span>
###xml 1311 1315 <span type="species:ncbi:10090">mice</span>
###xml 1329 1332 <span type="species:ncbi:12305?0.03296277145811789|species:ncbi:36410?3.8779731127197516E-4">CMV</span>
###xml 1337 1352 <span type="species:ncbi:10090">transgenic mice</span>
###xml 1395 1399 <span type="species:ncbi:10090">mice</span>
Phage clones containing mouse Hmox1 were isolated by screening of a 129/Svev genomic library (UK Human Genome Mapping Project Resource Centre) with a probe corresponding to the 5' end of mouse HO-1 cDNA. A targeting vector was designed to flank exons 3 and 4, with two loxP sites. The floxed neomycin-resistance gene fragment was inserted into intron 2 of Hmox1. A 5.2-kb NotI-NotI fragment (exons 1 and 2) was used as the 5' homology region; a 2.1-kb XhoI-SpeI fragment, which contains exons 3 and 4 of Hmox1, was inserted between the two loxP sites; and a 2.1-kb NheI-BamHI fragment was used as the 3' homology region. The herpes simplex virus thymidine kinase gene was used for negative selection of clones with random integration. A total of 20 microg of linearized vector was electroporated into 129/3 embryonic stem cells (provided by N. Brockdorff, University of Oxford, Oxford, England, UK). After positive and negative selection with G418 and gancyclovir, drug-resistant clones were picked up and screened by PCR and Southern blot analysis. These clones were individually microinjected into blastocysts derived from C57BL/6 mice and were transferred to pseudopregnant females. Matings of chimeric male mice to C57BL/6 female mice resulted in transmission of the floxed allele to the germline. Chimeric mice were bred to CMV-Cre transgenic mice (21) to remove the neomycin cassette. All mice were housed under specific pathogen-free conditions, and animal protocols used in this study were approved by the Institutional Animal Care and Use Committee of the Biomedical Sciences Research Center "Alexander Fleming."
###end p 35
###begin title 36
Cell cultures and reagents.
###end title 36
###begin p 37
###xml 52 53 52 53 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib1">1</xref>
###xml 55 57 55 57 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib48">48</xref>
###xml 296 297 293 294 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5</sup>
###xml 347 369 340 362 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Salmonella enteriditis</italic>
TEPMs and BMDMs were grown as previously described (1, 48). For the IFN-beta (PBL Biomedical Laboratories), IL-6 (Thermo Fisher Scientific), and TNF (provided by W. Buurman, Nutrition and Toxicology Research Institute Maastricht, Maastricht, Netherlands) ELISA assays, macrophage cultures (5 x 105 cells/well) were incubated with 1 microg/ml LPS (Salmonella enteriditis; Sigma-Aldrich) or 100 microg/ml polyI:C (GE Healthcare).
###end p 37
###begin title 38
Viral infections.
###end title 38
###begin p 39
###xml 119 120 119 120 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">6</sup>
###xml 0 3 <span type="species:ncbi:11191">SeV</span>
SeV Cantell strain was provided by D. Thanos (Academy of Athens, Athens, Greece) and was used to infect macrophages (106 cells/ml) at 100 hemagglutination U/ml for the time points indicated in the figures.
###end p 39
###begin title 40
Bacterial infections and assays to measure cell death.
###end title 40
###begin p 41
###xml 15 31 15 31 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">L. monocytogenes</italic>
###xml 82 84 82 84 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib30">30</xref>
###xml 102 103 102 103 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">6</sup>
###xml 135 151 135 151 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">L. monocytogenes</italic>
###xml 594 596 580 582 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib31">31</xref>
###xml 15 31 <span type="species:ncbi:1639">L. monocytogenes</span>
###xml 135 151 <span type="species:ncbi:1639">L. monocytogenes</span>
Preparation of L. monocytogenes and in vivo infections were previously described (30). Macrophages (106 cells/well) were infected with L. monocytogenes (derived from overnight culture) at different MOIs and incubated for 1 h at 37degreesC. Extracellular bacteria were subsequently killed with 50 microg/ml of gentamycin-containing medium. After another 60 min, the medium was changed to medium containing 10 microg/ml gentamycin, and the assay was incubated for 24 h. For crystal violet staining, cells were incubated for 20 min in 0.2% crystal violet in 20% methanol, as previously described (31).
###end p 41
###begin title 42
Immunoblot analysis, immunoprecipitation, and immunofluoresence staining.
###end title 42
###begin p 43
###xml 84 86 84 86 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib16">16</xref>
###xml 552 558 <span type="species:ncbi:9986">rabbit</span>
Immunoprecipitation and immunoblot analysis were performed as previously described (16). Membranes were blotted with antibodies to HO-1 (Assay Designs), p-Jnk, total Jnk, total p38, p-Erk, actin (Santa Cruz Biotechnology, Inc.), p-IkappaBalpha, p-p38, total IkappaBalpha, p-IRF3, p-IKKalpha/beta, IKKalpha and IKKbeta (Cell Signaling Technology), total IRF3 (Invitrogen), and TBK-1 (Millipore). For immunofluorescence staining, macrophages were stimulated with LPS or polyI:C for the periods indicated in the figures, permeabilized, and incubated with rabbit anti-IRF3 (Invitrogen).
###end p 43
###begin title 44
In vitro kinase assay.
###end title 44
###begin p 45
###xml 71 73 71 73 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib49">49</xref>
###xml 261 268 261 268 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E. coli</italic>
###xml 261 268 <span type="species:ncbi:110766|species:ncbi:562">E. coli</span>
The TBK-1 in vitro kinase assay was performed as previously described (49). Materials (polyclonal anti-TBK-1 antibody and glutathione S-transferase (GST)-IRF3 plasmid) were provided by J. Hiscott (McGill University, Montreal, Canada). GST-IRF3 was expressed in E. coli strain BL21(DE3)pLysS, and GST-IRF3 protein was purified using the MagneGST Protein Purification System (Promega) according to the manufacturer's instructions.
###end p 45
###begin title 46
EMSA.
###end title 46
###begin p 47
###xml 6 7 6 7 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">6</sup>
###xml 140 142 140 142 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib29">29</xref>
###xml 278 288 278 288 <underline xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GAAAGGGAAA</underline>
###xml 339 349 339 349 <underline xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TTTCCCTTTC</underline>
###xml 518 528 506 516 <underline xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GGGACTTTCC</underline>
###xml 531 540 519 528 <underline xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GGGGACTTT</underline>
###xml 563 575 547 559 <underline xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CGGAAAGTCCCC</underline>
###xml 578 588 562 572 <underline xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GGAAAGTCCC</underline>
5 x 106 TEPMs were treated with stimuli for various periods. Nuclear extracts were purified and EMSA was performed as previously described (29). The sequences of the oligonucleotides used for the ISG15 gene are as follows, with the ISRE sequence underlined: ISG15F (5'-GATCCTCGGGAAAGGGAAACCGAAACTGAAGCC-3') and ISG15R (5'-CGGGGCTTCAGTTTCGGTTTCCCTTTCCCGAG-3'). The sequences of the oligonucleotides used for NF-kappaB with two tandemly positioned NF-kappaB binding sites (underlined) were as follows: NFkappaBF (5'-ATCAGGGACTTTCCGCTGGGGACTTT-3') and NFkappaBR (5'-CGGAAAGTCCCCAGCGGAAAGTCCCT-3').
###end p 47
###begin title 48
Northern blot and RT-PCR analysis.
###end title 48
###begin p 49
###xml 26 29 26 29 <sc xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">zol</sc>
###xml 202 204 198 200 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">32</sup>
RNA was isolated using TRIzol reagent (Invitrogen). For Northern blot analysis, 20 microg of total RNA was separated in a 1.2% agarose-formaldehyde gel, transferred to nitrocellulose, and hybridized to 32P-labeled DNA probes. MCP1, MIP-1a, MIP-1b, RANTES, IP-10, and GAPDH probes were amplified from reverse-transcribed cDNA using the following oligonucleotides: MCP1f (5'-AGCACCAGCACCAGCCAACT-3'), MCP1r (5'-TTCCTTCTTGGGGTCAGCAC-3'), MIP-1af (5'-TCTCCACCACTGCCCTTGCT-3'), MIP-1ar (5'-CTCAGGCATTCAGTTCCAGG-3'), MIP-1bf (5'-GCAAACCTAACCCCGAGCAA-3'), MIP-1br (5'-TCCTGAAGTGGCTCCTCCTG-3'), RANTESf (5'-GCCCTCACCATCATCCTCAC-3'), RANTESr (5'-ATCCCATTTTCCCAGGACC-3'), IP-10f (5'-GCCGTCATTTTCTGCCTCAT-3'), IP-10r (5'-TCGCACCTCCACATAGCTTA-3'), GAPDHf (5'-TTAGCACCCCTGGCCAAGG-3'), and GAPDHr (5'-CTTACTCCTTGGAGGCCATG-3').
###end p 49
###begin p 50
For quantitative real-time RT-PCR, 5 microg of total RNA was used to make cDNA templates using M-MLV RT (Promega) and oligo-dT primers after treatment with RQ1 DNase I (Promega). Real-time PCR was performed on Chromo4 Real-Time PCR detection system (Bio-Rad Laboratories) using Platinum SYBR Green (Invitrogen). All data were normalized to beta2-microglobulin (beta2m) expression. Amplification conditions were 95degreesC for 4 min, followed by 40 cycles of 94degreesC for 30 s, 55degreesC for 30 s, and 72degreesC for 30 s. TLR4, TLR3, RIG-I, MDA5, PKR, and beta2m cDNAs were amplified using the following primers: TLR4f (5'-AAAAGTGAGAATGCTAAGGT-3'), TLR4r (5'-CGCAACGCAAGGATTTTATT-3'), TLR3f (5'-TGACGCACCTGTTCTCTATC-3'), TLR3r (5'-CGCAACGCAAGGATTTTATT-3'), RIG-If (5'-AGACAAAGAGGAGGAGAGCCG-3'), RIG-Ir (5'-ACGCCCAGTCAGTATGCCAG-3'), MDA5f (5'-AGGAGGCAGTCTATAACAAC-3'), MDA5r (5'-ATGGATTTTCTCTGGTGTCA-3'), PKRf (5'-TTGGCTTAGGTGGATTTGGT-3'), PKRr (5'-TTCTGTTTCTCATCCATTGC-3'), B2Mf (5'-TTCTGGTGCTTGTCTCACTGA-3'), and B2Mr (5'-CAGTATGTTCGGCTTCCCATTC-3').
###end p 50
###begin title 51
Induction of EAE and rIFN-beta treatment.
###end title 51
###begin p 52
###xml 56 58 56 58 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib48">48</xref>
###xml 78 81 <span type="species:ncbi:10116">rat</span>
###xml 97 100 <span type="species:ncbi:31658">CFA</span>
###xml 138 143 <span type="species:ncbi:10090">mouse</span>
Induction of EAE was performed as previously described (48) with 50 microg of rat MOG peptide in CFA containing a total of 1 mg H37Ra per mouse. rhIFN-beta (Betaferon; Schering-Plough) was administered for 14 d using mini-osmotic pumps (model 2002; Alzet).
###end p 52
###begin title 53
Spinal cord flow cytometry.
###end title 53
###begin p 54
###xml 57 59 57 59 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib50">50</xref>
Spinal cord cells were isolated as previously described (50). For flow cytometry, cells were stained for 30 min at 4degreesC with various primary antibodies (BD). Cells were analyzed with a flow cytometer (FACSCalibur; BD).
###end p 54
###begin title 55
Histological analysis.
###end title 55
###begin p 56
###xml 0 4 <span type="species:ncbi:10090">Mice</span>
Mice were perfused with PBS and spinal cords were fixed in 10% buffered formalin. The spinal cords were dissected and paraffin embedded before staining with hematoxylin and eosin (H&E) to assess inflammation, and luxol fast blue (LFB) to assess demyelination.
###end p 56
###begin title 57
Online supplemental material.
###end title 57
###begin p 58
###xml 457 461 450 454 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LysM</italic>
###xml 461 464 454 457 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Cre</italic>
###xml 461 466 454 459 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><italic>Cre</italic>/+</sup>
###xml 579 583 572 576 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">M-KO</sup>
###xml 619 624 612 617 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">35-55</sub>
###xml 482 486 <span type="species:ncbi:10090">mice</span>
###xml 596 600 <span type="species:ncbi:10090">mice</span>
Fig. S1 shows activation of the MAPK and NF-kappaB signaling cascades and proinflammatory cytokine production in HO-1-deficient macrophages. Fig. S2 depicts the induction of genes encoding LPS/dsRNA receptors in HO-1-deficient macrophages. Fig. S3 shows that HO-1 is not induced by IFN-beta or dsRNA and is induced by LPS. Fig. S4 shows that nuclear translocation of IRF3 is impaired in HO-1-deficient macrophages. Fig. S5 depicts the development of EAE in LysMCre/+ knockin and WT mice. Fig. S6 depicts the proliferation and cytokine production of LNs and spleen cells from HO-1M-KO and control mice immunized with MOG35-55. Table S1 shows the quantification of CNS-infiltrating cells during the chronic phase of EAE. Online supplemental material is available at .
###end p 58
###begin title 59
Supplementary Material
###end title 59
###begin title 60
[Supplemental Material Index]
###end title 60
###begin p 61
###xml 41 44 <span type="species:ncbi:11191">SeV</span>
We thank Dr. D. Thanos for providing the SeV, Prof. J. Hiscott for reagents for the TBK-1 assay, Dr. Neil Brockdorff for providing 129/3 embryonic stem cells, and S. Lalos and P. Athanasakis for technical support.
###end p 61
###begin p 62
This work was supported by European Commission grants QLK3-CT-2001-00422, MRTN-CT-2004-005693, LSHB-CT-2004-005276, and LSHG-CT-2005-005203 to G. Kollias.
###end p 62
###begin p 63
The authors declare no conflicting financial interests.
###end p 63
###begin article-title 64
Recognition of double-stranded RNA and activation of NF-kappaB by Toll-like receptor 3.
###end article-title 64
###begin article-title 65
###xml 52 56 <span type="species:ncbi:10090">mice</span>
Defective LPS signaling in C3H/HeJ and C57BL/10ScCr mice: mutations in Tlr4 gene.
###end article-title 65
###begin article-title 66
Small anti-viral compounds activate immune cells via the TLR7 MyD88-dependent signaling pathway.
###end article-title 66
###begin article-title 67
Species-specific recognition of single-stranded RNA via toll-like receptor 7 and 8.
###end article-title 67
###begin article-title 68
A Toll-like receptor recognizes bacterial DNA.
###end article-title 68
###begin article-title 69
Toll-like receptor signalling.
###end article-title 69
###begin article-title 70
Toll-like receptors in innate immunity.
###end article-title 70
###begin article-title 71
Differential roles of MDA5 and RIG-I helicases in the recognition of RNA viruses.
###end article-title 71
###begin article-title 72
Essential role of IPS-1 in innate immune responses against RNA viruses.
###end article-title 72
###begin article-title 73
Carbon monoxide differentially inhibits TLR signaling pathways by regulating ROS-induced trafficking of TLRs to lipid rafts.
###end article-title 73
###begin article-title 74
###xml 36 42 <span type="species:ncbi:10090">murine</span>
Carbon monoxide ameliorates chronic murine colitis through a heme oxygenase 1-dependent pathway.
###end article-title 74
###begin article-title 75
###xml 60 65 <span type="species:ncbi:9606">human</span>
Oxidative stress causes enhanced endothelial cell injury in human heme oxygenase-1 deficiency.
###end article-title 75
###begin article-title 76
Heme oxygenase 1 is required for mammalian iron reutilization.
###end article-title 76
###begin article-title 77
Reduced stress defense in heme oxygenase 1-deficient cells.
###end article-title 77
###begin article-title 78
Suppression of inflammatory cytokine production by carbon monoxide involves the JNK pathway and AP-1.
###end article-title 78
###begin article-title 79
Carbon monoxide has anti-inflammatory effects involving the mitogen-activated protein kinase pathway.
###end article-title 79
###begin article-title 80
###xml 76 80 <span type="species:ncbi:10090">mice</span>
Heme oxygenase-1 mediates the anti-inflammatory effect of interleukin-10 in mice.
###end article-title 80
###begin article-title 81
Heme oxygenase-1 and carbon monoxide suppress the pathogenesis of experimental cerebral malaria.
###end article-title 81
###begin article-title 82
Heme oxygenase 1 (HO-1) regulates osteoclastogenesis and bone resorption.
###end article-title 82
###begin article-title 83
Heme oxygenase-1 and carbon monoxide suppress autoimmune neuroinflammation.
###end article-title 83
###begin article-title 84
###xml 17 22 <span type="species:ncbi:10090">mouse</span>
A cre-transgenic mouse strain for the ubiquitous deletion of loxP-flanked gene segments including deletion in germ cells.
###end article-title 84
###begin article-title 85
###xml 73 77 <span type="species:ncbi:10090">mice</span>
Conditional gene targeting in macrophages and granulocytes using LysMcre mice.
###end article-title 85
###begin article-title 86
Convergence of the NF-kappaB and interferon signaling pathways in the regulation of antiviral defense and apoptosis.
###end article-title 86
###begin article-title 87
IRFs: master regulators of signalling by Toll-like receptors and cytosolic pattern-recognition receptors.
###end article-title 87
###begin article-title 88
IRF3 mediates a TLR3/TLR4-specific antiviral gene program.
###end article-title 88
###begin article-title 89
###xml 60 65 <span type="species:ncbi:9606">human</span>
Overlapping positive and negative regulatory domains of the human beta-interferon gene.
###end article-title 89
###begin article-title 90
Mechanisms of transcriptional synergism between distinct virus-inducible enhancer elements.
###end article-title 90
###begin article-title 91
Essential role of IRF-3 in lipopolysaccharide-induced interferon-beta gene expression and endotoxin shock.
###end article-title 91
###begin article-title 92
Transcriptional activity of interferon regulatory factor (IRF)-3 depends on multiple protein-protein interactions.
###end article-title 92
###begin article-title 93
###xml 56 78 56 78 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Listeria monocytogenes</italic>
###xml 56 78 <span type="species:ncbi:1639">Listeria monocytogenes</span>
Type I interferon production enhances susceptibility to Listeria monocytogenes infection.
###end article-title 93
###begin article-title 94
###xml 73 95 73 95 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Listeria monocytogenes</italic>
###xml 73 95 <span type="species:ncbi:1639">Listeria monocytogenes</span>
Production of type I IFN sensitizes macrophages to cell death induced by Listeria monocytogenes.
###end article-title 94
###begin article-title 95
IL-15 is expressed by dendritic cells in response to type I IFN, double-stranded RNA, or lipopolysaccharide and promotes dendritic cell activation.
###end article-title 95
###begin article-title 96
Type I interferons (alpha/beta) in immunity and autoimmunity.
###end article-title 96
###begin article-title 97
Multiple sclerosis.
###end article-title 97
###begin article-title 98
IFN-beta gene deletion leads to augmented and chronic demyelinating experimental autoimmune encephalomyelitis.
###end article-title 98
###begin article-title 99
Cutting Edge: TLR3 stimulation suppresses experimental autoimmune encephalomyelitis by inducing endogenous IFN-beta.
###end article-title 99
###begin article-title 100
Heme oxygenase-1: unleashing the protective properties of heme.
###end article-title 100
###begin article-title 101
###xml 42 47 <span type="species:ncbi:9796">horse</span>
Heme oxygenase: protective gene or Trojan horse.
###end article-title 101
###begin article-title 102
Identity of tumour necrosis factor and the macrophage-secreted factor cachectin.
###end article-title 102
###begin article-title 103
Interleukin 10 reduces the release of tumor necrosis factor and prevents lethality in experimental endotoxemia.
###end article-title 103
###begin article-title 104
Targeted expression of heme oxygenase-1 prevents the pulmonary inflammatory and vascular responses to hypoxia.
###end article-title 104
###begin article-title 105
Interaction between heme oxygenase-1 and -2 proteins.
###end article-title 105
###begin article-title 106
Heme oxygenase-1 protein localizes to the nucleus and activates transcription factors important in oxidative stress.
###end article-title 106
###begin article-title 107
Helix-turn-helix, zinc-finger, and leucine-zipper motifs for eukaryotic transcriptional regulatory proteins.
###end article-title 107
###begin article-title 108
Interleukin 17-producing CD4+ effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineages.
###end article-title 108
###begin article-title 109
###xml 139 145 <span type="species:ncbi:10090">murine</span>
Modulation of the IL-10/IL-12 cytokine circuit by interferon-beta inhibits the development of epitope spreading and disease progression in murine autoimmune encephalomyelitis.
###end article-title 109
###begin article-title 110
Interferon-beta directly influences monocyte infiltration into the central nervous system.
###end article-title 110
###begin article-title 111
Tumor necrosis factor (TNF) receptor shedding controls thresholds of innate immune activation that balance opposing TNF functions in infectious and inflammatory diseases.
###end article-title 111
###begin article-title 112
###xml 48 74 <span type="species:ncbi:11276">vesicular stomatitis virus</span>
Activation of TBK1 and IKKvarepsilon kinases by vesicular stomatitis virus infection and the role of viral ribonucleoprotein in the development of interferon antiviral immunity.
###end article-title 112
###begin article-title 113
IL-23 produced by CNS-resident cells controls T cell encephalitogenicity during the effector phase of experimental autoimmune encephalomyelitis.
###end article-title 113
###begin p 114
###xml 529 532 <span type="species:ncbi:11191">SeV</span>
###xml 534 546 <span type="species:ncbi:11191">Sendai virus</span>
Abbreviations used: AP-1, adaptor protein 1; BMDM, BM macrophage; CNS, central nervous system; EAE, experimental autoimmune encephalomyelitis; GST, glutathione S-transferase; HO-1, heme oxygenase-1; IRF, IFN regulatory factor; ISRE, IFN-stimulated response element; LFB, luxol fast blue; MAPK, mitogen-activated protein kinase; MDA5, melanoma differentiation-associated gene 5; MOG, myelin oligodendrocyte glycoprotein; MOI, multiplicity of infection; PKR, protein kinase regulated by RNA; RIG-I, retinoic acid-inducible gene I; SeV, Sendai virus; TEPM, thioglycollate-elicited peritoneal macrophage; TIR, TLR-IL-1R; TLR, Toll-like receptor; TRIF, TIR domain-containing adaptor inducing IFN-beta; WCE, whole-cell extract.
###end p 114

